September 3–5, 2020
Essen / Germany
PROGRAM  PROGRAMM
PROGRAM ▪ PROGRAMM
Download PDF   (684 KB)
PRE-PROGRAM  VORPROGRAMM

THURSDAY, SEPTEMBER 3, 2020

BREAST SURGERY WORKSHOP

ON DEMAND

ALCL
20 min.
Keynote Lecture
ALCL – The Change of a Daily Routine
P. Cordeiro, New York, NY (USA)
15 min.
Radiologic Diagnosis of ALCL
Ultrasound:A. Kümmel, Essen (D)
MRI, PET-CT:B. Gomez, Essen (D)
10 min.
Surgery in Case of Possible ALCL – The European View
M. Thill, Frankfurt/Main (D)
10 min.
Change from Textured to Smooth Surfaced
Implants: First Results
S. Kümmel, Essen (D)
STATEMENTS, PICTURE AND VIDEO LESSONS
20 min.
Keynote Lecture
OPBC: Oncoplastic Breast Consortium – What are the Unmet Needs for the Future in Oncoplastic Breast Surgery?
W. Weber, Basel (CH)
10 min.
Anatomic Preparation in NSM: Identification of Superficial Fascia
First Results in Oncological Safety and Cosmesis
S. Kümmel, Essen (D)
10 min.
Pre- or Subpectoral Implant Reconstruction after Mastectomy – Is There a Gold Standard?
J. Heil, Heidelberg (D)
10 min.
Breast Surgery – Discussion
S. Kümmel, Essen (D); R. Fabien, Paris (F); W. Weber, Basel (CH); B. Behr, Essen (D)

SURGICAL WORKSHOP
GYNECOLOGIC ONCOLOGY

ON DEMAND

30 min.
Plastic Reconstruction in Vulvar Cancer Surgery
S. Prader Brixen (I)
30 min.
Technique of Pelvic En-bloc Resection
S. Schneider, Essen (D)
30 min.
Diaphragm Surgery in Ovarian Cancer
T. Baert, Essen( D)
30 min.
Peri-operative Fluid Management for Ovarian Cancer Surgery – the Anesthesiologist’s Perspective
A. Feldheiser, Essen (D)
30 min.
Management of Bowel Anastomosis
A. du Bois, Essen (D)
30 min.
Technique, Indication and Postoperative Management of Splenectomy
C. Grimm, Wien (A)
30 min.
Technique and Indication for Lymphadenectomy in Ovarian Cancer
B. Ataseven, Essen (D)
30 min.
Endoscopic Para-aortic Lymphadenectomy
F. Lécuru, Paris (F)
MAIN PROGRAM  HAUPTPROGRAMM

FRIDAY, SEPTEMBER 4, 2020

GYNECOLOGIC ONCOLOGY

LIVE ON TAPE AND LIVE-DISCUSSION

PANEL
Moderators:A. du Bois, Essen (D); P. Harter, Essen (D)
Discussants:L. Chiva de Agustin, Madrid (E); N. Colombo, Milano (I); A. González Martín, Madrid (E)
MANAGEMENT OF RECURRENT OVARIAN CANCER
12.00 - 12.15 pm
Ongoing Trials in Gynecologic Oncology
F. Hilpert, Hamburg (D)
12.15 - 12.30 pm
DESKTOP III – A Practice Changer?
A. du Bois, Essen (D)
12.30 - 12.45 pm
SOC-1, GOG213 and DESKTOP III: Why is GOG 213 Negative?
D. Chi, New York, NY (USA)
12.45 - 1.00 pm
Live Discussion and Live Chat
Surgery of Recurrent Ovarian Cancer – A New Standard?
1.00 - 1.20 pm
„Platinum-sensitive“ is Outdated – What Means „Platinum is an Option“?
J. Ledermann, London (UK)
1.20 - 1.50 pm
BREAK and EXHIBITOR TALK
AN UPDATE ON ASSESSMENT AND DIAGNOSTICS
1.50 - 2.05 pm
Pitfals in Sentinel Diagnostics
N. Abu-Rustum, New York, NY (USA)
2.05 - 2.20 pm
How Reliable is Preoperative Imaging Today?
Ready to Build Strategic Decisions on It?
T. van Gorp, Leuven (B)
2.20 - 2.35 pm
Technique and Role of Laparoscopic Assessment in Gynecologic Oncology
A. Fagotti, Roma (I)
2.35 - 2.55 pm
Live Discussion and Live Chat
FOCUS ON CERVICAL CANCER
2.55 - 3.10 pm
Uterus Preserving Therapy in Cervical Cancer
N. Colombo, Milano (I)
3.10 – 3.15 pm
Live Discussion and Live Chat
3.15 - 3.45 pm
Risk Factors and Management of Fistula in Gynecological Oncology Surgery
Urinary Tract Fistula(3.15 - 3.30 pm)
C. Fotopoulou, London (UK) + Berlin (D)
Bowel Fistula(3.30 - 3.45 pm)
P. Alesina, Essen (D)
3.45 - 4.00 pm
Management of Bladder Dysfunction After Radical Pelvic Surgery
G. Aletti, Milano (I)
4.00 - 4.15 pm
Live Discussion and Live Chat
4.15 - 4.45 pm
BREAK and EXHIBITOR TALK
FRAILTY, WOUND HEALING AND MISCELLANEOUS
4.45 - 5.00 pm
How to Identify Fragility and Resilence Before Running Into a Disaster and How to Manage It?
J. Sehouli, Berlin (D)
5.00 - 5.15 pm
Wound Healing Disorders – After Vulvectomy
S. Mahner, München (D)
5.15 - 5.30 pm
Wound Healing Disorders – After Laparotomy/Abdomen Apertum
M.Z. Muallem, Berlin (D)
5.30 - 5.45 pm
Live Discussion and Live Chat
UPDATE ON SYSTEMIC TREATMENT IN GYNECOLOGIC ONCOLOGY
5.45 - 6.00 pm
Keynote Lecture
Systemic Therapy in Primary Ovarian Cancer: Bevacizumab and/or PARPi or Both? Ready for Primetime?
A. Gonzáles Martín, Madrid (E)
6.00 - 6.15pm
Risk-adapted Therapy Planning: Upfront Surgery or Chemotherapy First?
L. Chiva de Augustin, Madrid (E)
6.15 - 6.30 pm
Update on HIPEC: Is There Already a Role Outside Clinical Trials?
G. Scambia, Roma (I)
6.30 - 6.45 pm
Live Discussion and Live Chat

SATURDAY, SEPTEMBER 5, 2020

BREAST CANCER

LIVE ON TAPE AND LIVE-DISCUSSION

CHAIR
S. Kümmel, Essen (D); O. Gluz, Mönchengladbach (D)
UPDATE ON SYSTEMIC TREATMENT IN BREAST CANCER
9.00 - 10.00 am
Breast Cancer – What is Proven, What is Coming Next?
From Early to Metastatic Disease
Triple Negative(9.00 - 9.20 am)
P. Schmid, London (UK)
HER2 Overexpression(9.20 - 9.40 am)
J. Cortes, Madrid (E) + Barcelona (E)
De-Escalation(9.40 - 10.00 am)
O. Gluz, Möchengladbach (D)
10.00 - 10.15 am
Live Discussion and Live Chat
LOCAL THERAPY – SOLUTIONS FOR COMPLICATIONS
10.15 - 10.25 am
Is Radiation of 1–2 Weeks Possible in Breast Cancer?
R. Galalae, Wien (A)
10.25 - 10.35 am
Radiotherapy and Implants (Thoracic Wall Radiation in pN+ or Only LAW etc.)
K. Ferentinos, Limassol (CY)
10.35 - 10.45 am
Surgery after Complications – From Infection to Necrosis
F. Reyal, Paris (F)
10.45 - 11.00 pm
Joint Lecture: Integrative Oncology in Case of Surgical Complications
G. Dobos, Essen (D)
11.00 - 11.20 am
Live Discussion and Live Chat
Chair + Discussants:R. Galalae, Wien (A); F. Reyal, Paris (F)
11.20 - 11.40 am
BREAK and EXHIBITOR TALK
LOCAL THERAPY – AXILLA SURGERY
11.40 am - 12.10 pm
Management: Clinical Lymph Node Positive Situations in the Era of Post-neoadjuvant Approaches
SENTA Trial: Final Results(11.40 - 11.50 am)
M. Reinisch, Essen (D)
Institute Curie Experience(1.50 - 12.00 am)
F. Reyal, Paris (F)
MD Anderson Experience(12.00 - 12.10 pm))
A. Caudle, Houston TX (USA)
12.10 - 12.20 pm
New Ideas – Ongoing Trials in Europe
W. Weber, Basel (CH)
12.20 - 12.35 pm
Live Discussion and Live Chat
Chair + Discussants:F. Reyal, Paris (F); W. Weber, Basel (CH)
RECONSTRUCTIVE SURGERY
12.35 - 12.50 pm
PRO:  We Need Meshes/ADMs in Subcutaneous Implant Reconstruction
D. Gschwantler-Kaulich, Wien (A)
12.50 - 1.05 pm
CONTRA:  We Do Not Need Meshes/ADMs in Subcutaneous Implant Reconstruction
S. Potter, Bristol (UK)
1.05 - 1.15 pm
Flap Reconstruction: Where DIEP is Not Possible (TMG, FCI, LICAP etc.)
B. Behr, Bochum (D)
1.15 - 1.30 pm
Live Discussion and Live Chat
Chair + Discussants:B. Behr, Bochum (D); F. Reyal, Paris (F)